Vizient Joins White House Roundtable on Cancer Drug Shortages

IRVING, Texas, July 28, 2023 – Today, Vizient, Inc. participated in a White House roundtable discussion on cancer drug shortages, where Vizient pharmacy expert Mittal Sutaria, PharmD, Senior Vice President, Contract and Program Services shared insights regarding Vizient's work on behalf of its providers to mitigate harm caused by supply disruptions. Attended by an esteemed group of participants from across the supply chain and within the administration, the discussion focused on how to ensure patients have access to cancer drugs during shortages and how to build resilience into the supply of these drugs.

As the only group purchasing organization represented at the White House, Vizient has a long-standing commitment to partnering across the supply chain to create innovative solutions to enhance supply chain assurance. Vizient appreciates the administration's efforts to bring together key industry stakeholders to discuss ongoing pharmaceutical supply challenges, and we look forward to continuing to collaborate with government and healthcare partners to end drug shortages.

About Vizient, Inc.
Vizient, Inc., the nation's largest health care performance improvement company, serves more than 50% of the nation's acute care providers, which includes 97% of the nation's academic medical centers, and more than 25% of the non-acute market. Vizient provides expertise, analytics and advisory services, as well as a contract portfolio that represents more than $130 billion in annual purchasing volume. Vizient's solutions and services improve the delivery of high-value care by aligning cost, quality and market performance. Headquartered in Irving, Texas, Vizient has offices throughout the United States. Learn more at www.vizientinc.com.